Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Dec 28 2021

Erythropoietin

  • Snapshot
    • A 50-year-old man with a history of chronic kidney disease presents to the emergency room for fatigue. He reports he has felt short of breath and fatigued for the past few months. Physical exam shows a man with significant pallor. On laboratory examination, his hemoglobin is found to be 8 g/dL with decreased reticulocyte count. He is given epoeitin alfa with a target hemoglobin of 11 g/dL.
  • introduction
    • Drugs
      • epoetin alpha
        • recombinant human erythropoietin
          • erythropoietin is physiologically released by the kidney in response to hypoxia
    • Mechanism of action
      • stimulates red blood cell production by the bone marrow
    • Clinical use
      • anemia of renal failure
      • bone marrow suppression
      • chemotherapy-induced anemia
      • drug-induced anemia
    • Adverse effects
      • fever
      • nausea and vomiting
      • rash
      • pruritus
      • increased hematocrit leading to thrombosis
      • hypertension
Card
1 of 0
Private Note